The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive.
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive.
In trading on Thursday, shares of the iShares MSCI Netherlands ETF (Symbol: EWN) crossed below their 200 day moving average of $57.26, changing hands as low as $56.98 per share. iShares MSCI Netherlands shares are currently trading off about 2.4% on the day. The chart below sh
In trading on Thursday, shares of the iShares MSCI Netherlands ETF (Symbol: EWN) crossed below their 200 day moving average of $57.26, changing hands as low as $56.98 per share. iShares MSCI Netherlands shares are currently trading off about 2.4% on the day. The chart below sh
In trading on Thursday, shares of the VanEck Uranium+Nuclear Energy ETF (Symbol: NLR) crossed below their 200 day moving average of $131.15, changing hands as low as $130.38 per share. VanEck Uranium+Nuclear Energy shares are currently trading off about 4% on the day. The char
In trading on Thursday, shares of the VanEck Uranium+Nuclear Energy ETF (Symbol: NLR) crossed below their 200 day moving average of $131.15, changing hands as low as $130.38 per share. VanEck Uranium+Nuclear Energy shares are currently trading off about 4% on the day. The char
In trading on Thursday, shares of Coeur Mining Inc (Symbol: CDE) crossed below their 200 day moving average of $16.46, changing hands as low as $16.22 per share. Coeur Mining Inc shares are currently trading down about 8.5% on the day. The chart below shows the one year perfor
In trading on Thursday, shares of Coeur Mining Inc (Symbol: CDE) crossed below their 200 day moving average of $16.46, changing hands as low as $16.22 per share. Coeur Mining Inc shares are currently trading down about 8.5% on the day. The chart below shows the one year perfor
In trading on Thursday, shares of the WisdomTree U.S. LargeCap Fund ETF (Symbol: EPS) crossed below their 200 day moving average of $68.60, changing hands as low as $67.60 per share. WisdomTree U.S. LargeCap Fund shares are currently trading off about 1.8% on the day. The char
In trading on Thursday, shares of the WisdomTree U.S. LargeCap Fund ETF (Symbol: EPS) crossed below their 200 day moving average of $68.60, changing hands as low as $67.60 per share. WisdomTree U.S. LargeCap Fund shares are currently trading off about 1.8% on the day. The char
MSTORY/iStock via Getty Images Investment Overview: Wave Life Stock Tumbles On Obesity Data Release The stock of Wave Life Sciences Ltd. ( WVE ) is down >50% so far today, trading at a value of ~$6 at the time of writing (market cap of $1.2bn), after the Singapore-headquartered biotech reported "positive" interim data from its INLIGHT study evaluating WVE-007, an investigational INHBE GalNAc-siRNA...
MSTORY/iStock via Getty Images Investment Overview: Wave Life Stock Tumbles On Obesity Data Release The stock of Wave Life Sciences Ltd. ( WVE ) is down >50% so far today, trading at a value of ~$6 at the time of writing (market cap of $1.2bn), after the Singapore-headquartered biotech reported "positive" interim data from its INLIGHT study evaluating WVE-007, an investigational INHBE GalNAc-siRNA (SpiNA design), in otherwise healthy individuals living with overweight or obesity. Here is how the company's discusses WVE-007 in its press release today: WVE-007 is an investigational GalNAc-siRNA that utilizes Wave’s best-in-class proprietary oligonucleotide chemistry and the company’s Stereopure interfering Nucleic Acid (SpiNA) next generation siRNA design. WVE-007 is designed to silence INHBE mRNA, an obesity target with strong evidence from human genetics. Individuals who have a protective loss-of-function variant in one copy of the INHBE gene have a healthier body composition and cardiometabolic profile, including less visceral fat and lower risk of type 2 diabetes or cardiovascular disease. In preclinical models, INHBE GalNAc-siRNA led to adipocyte shrinkage, fewer pro-inflammatory macrophages, less fibrosis, and improved insulin sensitivity in visceral adipose tissue, supporting potential for metabolic improvement. As an add-on to semaglutide, Wave’s GalNAc-siRNA doubled weight loss in mice and prevented weight regain upon cessation of semaglutide. In summary, then, this is an obesity drug, but it is not a glucagon-like peptide-1 ("GLP-1") agonist, like Novo Nordisk's ( NVO ) semaglutide, or Wegovy (in the obesity indication), which earned nearly $12bn dollars of revenues in 2025, or indeed a dual agonist of GLP-1 and a glucose-dependent insulinotropic polypeptide ("GIP"), like Eli Lilly's ( LLY ) tirzepatide, or Zepbound (in the obesity indication), which earned ~$13.5bn revenues last year. WAVE-007 - Overview Of Mechanism Of Action ("MoA") An overview of how Wav...
In trading on Thursday, shares of the iShares MSCI Switzerland ETF (Symbol: EWL) crossed below their 200 day moving average of $57.48, changing hands as low as $57.39 per share. iShares MSCI Switzerland shares are currently trading down about 1.3% on the day. The chart below s
In trading on Thursday, shares of the iShares MSCI Switzerland ETF (Symbol: EWL) crossed below their 200 day moving average of $57.48, changing hands as low as $57.39 per share. iShares MSCI Switzerland shares are currently trading down about 1.3% on the day. The chart below s
In trading on Thursday, shares of the iShares Europe ETF (Symbol: IEV) crossed below their 200 day moving average of $66.72, changing hands as low as $66.14 per share. iShares Europe shares are currently trading down about 1.8% on the day. The chart below shows the one year pe
In trading on Thursday, shares of the iShares Europe ETF (Symbol: IEV) crossed below their 200 day moving average of $66.72, changing hands as low as $66.14 per share. iShares Europe shares are currently trading down about 1.8% on the day. The chart below shows the one year pe
Dmitry Vinogradov U.S. stocks retreated decisively on Thursday, as rising tensions between the United States and Iran unsettled markets and dampened risk appetite across asset classes. Technology shares bore the brunt of the selling, pulling the Nasdaq Composite ( COMP:IND ) down 2.3% amid continued weakness in growth-oriented names. The broader S&P 500 ( SP500 ) declined 1.7%, while the Dow Jones...
Dmitry Vinogradov U.S. stocks retreated decisively on Thursday, as rising tensions between the United States and Iran unsettled markets and dampened risk appetite across asset classes. Technology shares bore the brunt of the selling, pulling the Nasdaq Composite ( COMP:IND ) down 2.3% amid continued weakness in growth-oriented names. The broader S&P 500 ( SP500 ) declined 1.7%, while the Dow Jones Industrial Average ( DJI ) fell 1%, highlighting widespread declines across the market. Now, here are three focus points for investors on Friday: Traders will be closely watching Friday’s release of the University of Michigan Consumer Sentiment Index after the open, as investors seek fresh insight into the health of the U.S. consumer and overall economic momentum. The report will be closely analyzed for shifts in inflation expectations and household confidence, both of which could shape the outlook for consumer spending and influence the Federal Reserve’s policy trajectory. Market participants will also be closely watching Carnival Corporation’s ( CCL ) upcoming earnings release, as investors look for fresh insight into travel demand trends and the strength of consumer spending on discretionary leisure. The report will be scrutinized for booking trends, pricing power, and forward guidance information. Investors will be closely watching oil ( CL1:COM ) prices on as the ongoing U.S.-Iran conflict continues to drive volatility across energy markets and broader risk sentiment. Crude settled above $94 per barrel on Thursday, and traders will be monitoring for further price swings tied to geopolitical developments and potential supply disruptions, particularly around key transit routes like the Strait of Hormuz. What do you think is next for Social Security? Share your opinion in our user poll . More on markets 20 dividend stocks to watch as the Middle East conflict continues to shake markets OECD lifts G20 inflation outlook as rising energy prices impact global markets Exxon Mo...
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive.
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive.
In trading on Thursday, shares of the ProShares UltraShort Technology ETF (Symbol: REW) crossed above their 200 day moving average of $12.34, changing hands as high as $12.62 per share. ProShares UltraShort Technology shares are currently trading up about 5.7% on the day. The
In trading on Thursday, shares of the ProShares UltraShort Technology ETF (Symbol: REW) crossed above their 200 day moving average of $12.34, changing hands as high as $12.62 per share. ProShares UltraShort Technology shares are currently trading up about 5.7% on the day. The
Both iShares MSCI Emerging Markets ETF (NYSEMKT:EEM) and iShares Core MSCI Total International Stock ETF (NASDAQ:IXUS) are popular iShares offerings for international exposure, but they serve distinct purposes: IXUS provides comprehensive access to developed and emerging non-U.S. stocks, while EEM zeroes in on large- and mid-cap companies from emerging markets. EEM carries a substantially higher e...
Both iShares MSCI Emerging Markets ETF (NYSEMKT:EEM) and iShares Core MSCI Total International Stock ETF (NASDAQ:IXUS) are popular iShares offerings for international exposure, but they serve distinct purposes: IXUS provides comprehensive access to developed and emerging non-U.S. stocks, while EEM zeroes in on large- and mid-cap companies from emerging markets. EEM carries a substantially higher expense ratio and narrower portfolio than IXUS, but it also posted a stronger one-year total return and leans more heavily into technology and emerging-market equities. This comparison breaks down their cost, diversification, sector tilts, and risk profiles to help investors assess which approach may better fit their goals. Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Continue reading
May NY world sugar #11 (SBK26 ) on Thursday closed up +0.32 (+2.06%), and May London ICE white sugar #5 (SWK26 ) closed up +5.60 (+1.23%). Sugar prices rallied sharply on Thursday, with NY sugar posting a 5.5-month high. Sugar prices rallied in sympathy with Thursday's +4% surge in crude...
May NY world sugar #11 (SBK26 ) on Thursday closed up +0.32 (+2.06%), and May London ICE white sugar #5 (SWK26 ) closed up +5.60 (+1.23%). Sugar prices rallied sharply on Thursday, with NY sugar posting a 5.5-month high. Sugar prices rallied in sympathy with Thursday's +4% surge in crude...
In trading on Thursday, shares of the Capital Group Short Duration Income ETF (Symbol: CGSD) entered into oversold territory, changing hands as low as $25.78 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicat
In trading on Thursday, shares of the Capital Group Short Duration Income ETF (Symbol: CGSD) entered into oversold territory, changing hands as low as $25.78 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicat
Google released new tools for its Gemini artificial intelligence assistant that will let users upload chat history and context from other AI apps, a move to lure users from rivals like OpenAI’s ChatGPT and Anthropic PBC’s Claude. The Alphabet Inc. company has added a new import option in Gemini so that free and paid users can upload zipped files of their conversations with other AI providers, it s...
Google released new tools for its Gemini artificial intelligence assistant that will let users upload chat history and context from other AI apps, a move to lure users from rivals like OpenAI’s ChatGPT and Anthropic PBC’s Claude. The Alphabet Inc. company has added a new import option in Gemini so that free and paid users can upload zipped files of their conversations with other AI providers, it said in a blog post on Thursday. To aid the switch, Google provides a detailed prompt that users can offer as instructions for their other apps: “You are helping me import context from one AI assistant to another.” The prompt further asks people to note any demographic information, active interests and preferences, sustained relationships, dated plans and any other instructions they had disclosed to their other chat assistants. The output, which people paste into Gemini’s settings, will be used to “quickly get Gemini up to speed on what matters most to you,” Google said. AI providers are looking for ways to entice people from rivals to gain market share. Anthropic released a similar memory import feature earlier this month, in an effort to hang on to new users it gained amid its feud with the US government. Read More: Anthropic Tries to Win Users From ChatGPT With Memory Feature
magicmine/iStock via Getty Images Madrigal Pharmaceuticals ( MDGL ) rose 12% amid renewed speculation it could be a takeover target, according to traders, who cited a Betaville "uncooked" alert that was circulating on Thursday. Betaville reported in January 2025 that Madrigal ( MDGL ) had hired advisers for t alks with a potential buyer. Madrigal ( MDGL ) has a market cap of $12 billion. Madrigal ...
magicmine/iStock via Getty Images Madrigal Pharmaceuticals ( MDGL ) rose 12% amid renewed speculation it could be a takeover target, according to traders, who cited a Betaville "uncooked" alert that was circulating on Thursday. Betaville reported in January 2025 that Madrigal ( MDGL ) had hired advisers for t alks with a potential buyer. Madrigal ( MDGL ) has a market cap of $12 billion. Madrigal ( MDGL ) has short interest of 16%. More on Madrigal Pharmaceuticals, Inc. Madrigal: The Easiest Money May Have Been Made Madrigal Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call Transcript Madrigal outlines robust 2026 net sales growth and expanding pipeline amid 50% MASH market surge Madrigal down after wider-than-expected Q4 loss
Palantir-partner Ondas Holdings has significant upside compared with current trading levels, according to recent analyst notes following fourth-quarter earnings.
Palantir-partner Ondas Holdings has significant upside compared with current trading levels, according to recent analyst notes following fourth-quarter earnings.